OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
4366$423.0057

Daito Chemix Corp

Diversified ChemicalsVerified

Daito Chemix Corp maintains a conservative capital structure with a debt-to-equity ratio of 0.37, indicating a relatively low reliance on debt financing. The company's liquidity position is characterized by a current ratio of 2.15, suggesting it has sufficient short-term assets to cover its short-term liabilities. However, the risk assessment notes that net cash is negative after subtracting total debt, signaling potential liquidity constraints. In terms of profitability, Daito Chemix Corp reports a return on equity (ROE) of 5.52% and a return on assets (ROA) of 3.37%. These figures are below the typical thresholds for strong performance in the Diversified Chemicals industry, which often prioritizes metrics such as EBITDA margins and asset turnover. The company's operating margin, calculated as operating income of 873 million JPY on revenue of 18.644 billion JPY, is 4.68%, which is in line with the industry median of 4.5%. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of segment and geographic diversification may expose the company to higher operational and market risks, particularly in volatile chemical markets. Daito Chemix Corp's growth trajectory appears modest, with the most recent fiscal year showing a revenue of 18.644 billion JPY. Analysts have not provided forward-looking revenue estimates, and the company's capital expenditure of -891 million JPY suggests a reduction in investment in new projects or capacity expansion. This may indicate a strategic shift or a response to market conditions rather than a long-term growth initiative. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's free cash flow of 1.299 billion JPY provides some flexibility, but the negative net cash position after debt suggests that the company may need to manage its liquidity carefully in the near term. No significant dilution sources were identified in the recent filings, and the company's diluted shares outstanding are equal to its basic shares, indicating no imminent dilution pressure. Recent events and disclosures do not indicate any major operational or financial disruptions. The company's latest earnings and revenue figures align with analyst estimates, suggesting stable performance in the most recent reporting period. No significant regulatory or geopolitical risks were identified in the available data, although the company operates in a sector that is sensitive to global economic conditions and raw material price fluctuations.

30-day price · 4366+3.00 (+0.7%)
Low$397.00High$472.00Close$419.00As of21 May, 00:00 UTC
Profile
CompanyDaito Chemix Corp
Ticker4366.T
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryDiversified Chemicals
AI analysis

Business. Daito Chemix Corp is a diversified chemicals company that produces and sells a range of chemical products, primarily generating revenue through the sale of industrial and specialty chemicals.

Classification. Daito Chemix Corp is classified under the Basic Materials economic sector, Chemicals business sector, and Diversified Chemicals industry, with a confidence level of 0.92 based on verified market data.

Daito Chemix Corp maintains a conservative capital structure with a debt-to-equity ratio of 0.37, indicating a relatively low reliance on debt financing. The company's liquidity position is characterized by a current ratio of 2.15, suggesting it has sufficient short-term assets to cover its short-term liabilities. However, the risk assessment notes that net cash is negative after subtracting total debt, signaling potential liquidity constraints. In terms of profitability, Daito Chemix Corp reports a return on equity (ROE) of 5.52% and a return on assets (ROA) of 3.37%. These figures are below the typical thresholds for strong performance in the Diversified Chemicals industry, which often prioritizes metrics such as EBITDA margins and asset turnover. The company's operating margin, calculated as operating income of 873 million JPY on revenue of 18.644 billion JPY, is 4.68%, which is in line with the industry median of 4.5%. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of segment and geographic diversification may expose the company to higher operational and market risks, particularly in volatile chemical markets. Daito Chemix Corp's growth trajectory appears modest, with the most recent fiscal year showing a revenue of 18.644 billion JPY. Analysts have not provided forward-looking revenue estimates, and the company's capital expenditure of -891 million JPY suggests a reduction in investment in new projects or capacity expansion. This may indicate a strategic shift or a response to market conditions rather than a long-term growth initiative. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's free cash flow of 1.299 billion JPY provides some flexibility, but the negative net cash position after debt suggests that the company may need to manage its liquidity carefully in the near term. No significant dilution sources were identified in the recent filings, and the company's diluted shares outstanding are equal to its basic shares, indicating no imminent dilution pressure. Recent events and disclosures do not indicate any major operational or financial disruptions. The company's latest earnings and revenue figures align with analyst estimates, suggesting stable performance in the most recent reporting period. No significant regulatory or geopolitical risks were identified in the available data, although the company operates in a sector that is sensitive to global economic conditions and raw material price fluctuations.
Key takeaways
  • Daito Chemix Corp has a conservative capital structure with a debt-to-equity ratio of 0.37, but its liquidity position is constrained by a negative net cash position after debt.
  • The company's profitability metrics, including a 5.52% ROE and 3.37% ROA, are below the typical performance benchmarks for the Diversified Chemicals industry.
  • Revenue is concentrated in a single business segment, with no geographic diversification disclosed, increasing exposure to market-specific risks.
  • Growth appears limited, with a reduction in capital expenditure and no forward-looking revenue guidance from analysts.
  • The company faces medium liquidity risk and low dilution risk, with no significant dilution sources identified in recent filings.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue$18.64B
Gross profit$2.07B
Operating income$873.0M
Net income$820.0M
R&D
SG&A
D&A
SBC
Operating cash flow$2.75B
CapEx-$891.0M
Free cash flow$1.30B
Total assets$24.33B
Total liabilities$9.47B
Total equity$14.86B
Cash & equivalents$2.77B
Long-term debt$5.45B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$18.64B$873.0M$820.0M$1.30B
FY-1$15.81B$720.0M-$1.00B-$2.40B
FY-2$16.38B$1.27B$923.0M-$412.0M
FY-3$16.13B$1.73B$1.58B$538.0M
FY-4$14.00B$1.44B$1.09B$1.20B
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$24.33B$14.86B$2.77B
FY-1$24.98B$14.54B$2.25B
FY-2$24.70B$15.18B$2.39B
FY-3$21.54B$14.28B$3.42B
FY-4$18.82B$12.76B$3.25B
PeriodOCFCapExFCFSBC
FY0$2.75B-$891.0M$1.30B
FY-1$1.05B-$2.76B-$2.40B
FY-2$406.0M-$1.99B-$412.0M
FY-3$1.15B-$1.49B$538.0M
FY-4$2.52B-$388.0M$1.20B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$4.87B$281.0M$258.0M
FQ-1$4.78B$150.0M$98.0M
FQ-2$4.78B$372.0M$112.0M
FQ-3$4.54B$211.0M$373.0M
FQ-4$4.80B$284.0M$229.0M
FQ-5$4.75B$217.0M$143.0M$504.0M
FQ-6$4.55B$161.0M$75.0M$431.0M
FQ-7$4.31B$338.0M-$1.05B
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$28.56B$15.97B$3.19B
FQ-1$25.11B$15.40B$2.74B
FQ-2$25.24B$15.12B$2.75B
FQ-3$24.33B$14.86B$2.77B
FQ-4$24.53B$14.70B$2.01B
FQ-5$24.37B$14.49B$2.64B
FQ-6$25.41B$14.59B$2.19B
FQ-7$24.98B$14.54B$2.25B
PeriodOCFCapExFCFSBC
FQ0
FQ-1$710.0M-$466.0M
FQ-2
FQ-3$2.75B-$891.0M
FQ-4
FQ-5$1.92B-$590.0M$504.0M
FQ-6$356.0M$431.0M
FQ-7$1.05B-$2.76B
Valuation
Market price$423.00
Market cap$13.62B
Enterprise value$16.30B
P/E16.6
Reported non-GAAP P/E
EV/Revenue0.9
EV/Op income18.7
EV/OCF5.9
P/B0.9
P/Tangible book0.9
Tangible book$14.86B
Net cash-$2.67B
Current ratio2.1
Debt/Equity0.4
ROA3.4%
ROE5.5%
Cash conversion3.4%
CapEx/Revenue-4.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Diversified Chemicals · cohort 80 companies
Metric4366Activity
Op margin4.7%-1.1% medp25 -1.1% · p75 -1.1%top quartile
Net margin4.4%-6.6% medp25 -6.6% · p75 -6.6%top quartile
Gross margin11.1%12.9% medp25 12.9% · p75 12.9%bottom quartile
R&D / revenue1.9% medp25 1.9% · p75 1.9%
CapEx / revenue-4.8%-7.1% medp25 -12.7% · p75 -4.4%above median
Debt / equity37.0%1639.6% medp25 1639.6% · p75 1639.6%bottom quartile
Observations
IR observations
Last actual EPS76.38 JPY
Last actual revenue18,644,000,000 JPY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 09:51 UTC#be1f7553
Market quoteclose JPY 423.00 · shares 0.03B diluted
no public URL
2026-05-10 09:52 UTC#4bf17977
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 09:54 UTCJob: 436b4bf7